08 Dec, 2025,

BREAKING NEWS: JioStar Abandons $3 Billion ICC Deal Amid Massive Losses - IPL's Future Valuation in Jeopardy

In a dramatic development that threatens to reshape India's cricket broadcasting landscape, Reliance Industries-controlled JioStar has formally notified the International Cricket Council (ICC) th...

08 Dec, 2025,

1678 3

26 Oct, 2025,

1819 3

PharmEasy’s Lifeline? Docon Offloads 10% Stake in Thyrocare for ₹668 C...

PharmEasy’s parent, API Holdings, has been struggling for the last two years with tight liquidity, debt refinancing challenges, and delayed IPO plans. But now, a major promoter transaction in Thyrocare Technologies, the most profitable business under its umbrella, might finally provide breathing room. On 24th October 2025, Docon Technologies Private Limited, a 100% subsidiary of API Holding...

26 Oct, 2025,

1819 3

18 Sep, 2025,

2026 6

PharmEasy’s Fresh Debt Raise: A Deeper Look into the ₹1,700 Crore Move

Introduction PharmEasy, one of Mumbai’s leading health-tech unicorns, has taken a decisive financial step by raising ₹1,700 crore in a debt round. The capital will primarily be used to repay a costly Goldman Sachs loan, underscoring the company’s efforts to balance between aggressive expansion and financial discipline. This development reflects both the challenges and strategic pivots...

18 Sep, 2025,

2026 6

07 Aug, 2025,

741 1

PharmEasy CEO Siddharth Shah Steps Down; Rahul Guha Appointed New MD &...

In a major leadership transition at API Holdings, the parent company of digital health unicorn PharmEasy, co-founder and CEO Siddharth Shah has stepped down from his executive position. Rahul Guha, who currently serves as CEO of Thyrocare and President of Operations at API, has been appointed the new Managing Director and CEO of API Holdings, effective August 27, 2025. This development comes amid...

07 Aug, 2025,

741 1

23 Jun, 2025,

2412 0

All Home: PharmEasy Founders' New Disruptive Venture in India's Interi...

Executive Summary All Home, founded by the core team behind PharmEasy, is revolutionizing India's $30B+ interior design industry. The startup, now valued at $120 million in its Pre-Series A round, is leveraging a tech-first, asset-light model to deliver AI-powered design and seamless project execution. Backed by Bessemer Venture Partners, All Home aims to become the go-to platform for mid-to-prem...

23 Jun, 2025,

2412 0

10 May, 2025,

565 0

PharmEasy Ups Diagnostic Game with 'On-Time or Free' Promise

PharmEasy, one of India's leading digital healthcare platforms, has launched a fresh marketing campaign designed to drive adoption and trust in its diagnostic testing services. At the center of this initiative lies a compelling promise—*"on-time or free"*—which directly tackles one of the most frustrating issues customers face: delayed sample collections. A Familiar Jingle Returns wit...

10 May, 2025,

565 0

03 Dec, 2024,

838 3

PharmEasy’s Struggles and Investment Returns: A Look into Prosus’ Port...

In the first half of the fiscal year, online pharmacy startup PharmEasy delivered disappointing results for global investment firm Prosus, posting an internal rate of return (IRR) of -38%. This underperformance mirrors a continuing trend, with PharmEasy’s IRR at a far worse -44% during the same period in FY24. Despite attempts to cut its losses, PharmEasy is still facing significant hurdles...

03 Dec, 2024,

838 3

07 Nov, 2024,

645 4

AIOCD Raises Concerns Over Potential Instamart-PharmEasy Partnership f...

AIOCD Raises Concerns Over Potential Instamart-PharmEasy Partnership for 10-Minute Medicine Delivery The All India Organisation of Chemists and Druggists (AIOCD) has raised significant alarm over a proposed collaboration between Swiggy’s grocery delivery service, Instamart, and e-pharmacy leader PharmEasy. This partnership aims to facilitate medicine delivery within a 10-minute window using...

07 Nov, 2024,

645 4

10 Sep, 2024,

3981 9

Comprehensive Report on PharmEasy's FY24 Financial Performance

Comprehensive Report on PharmEasy's FY24 Financial Performance Introduction PharmEasy, a leading digital healthcare platform in India, has made significant strides in optimizing its operations and focusing on higher-margin segments. The fiscal year 2024 (FY24) has been a challenging yet transformative year for the company. This report provides a detailed analysis of PharmEasy's business model, f...

10 Sep, 2024,

3981 9

26 Jul, 2024,

573 3

Pharmeasy Subsidiary, Thyrocare Expands Northern India Footprint with...

Thyrocare Technologies has expanded its presence in Northern India by acquiring the pathology business of Polo Labs. The acquisition aims to enhance Thyrocare's diagnostic capabilities in the region, promising faster services and greater convenience for patients. The deal involves integrating Polo Labs' 14 laboratories, spread across Punjab, Haryana, and Himachal Pradesh, into Thyrocare's existin...

26 Jul, 2024,

573 3